Source: http://ipbiz.blogspot.com/2019/03/
Timestamp: 2019-04-22 16:13:21+00:00

Document:
“TEK”) for infringement of U.S. Patent No.
far. In SSI II, SSI raised only one obviousness theory.
and Bridgestone that were not before this court in SSI II.
462 F.3d 1344, 1354 (Fed. Cir. 2006)).
then, if necessary, to the extrinsic evidence. See Phillips v.
AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc).
ineligible under 35 U.S.C. § 101. See Endo Pharms. Inc. v.
recommendation, 2015 WL 5580488 (D. Del.
available dose” for patients with renal impairment. Id.
at col. 10 ll. 26–27, 40–41.
We held similar claims patent-eligible in Vanda Pharmaceuticals Inc. v.
West-Ward Pharmaceuticals International Ltd, 887 F.3d 1117 (Fed. Cir. 2018).
is a “CYP2D6 poor metabolizer.” 887 F.3d at 1121.
testing. Additionally, the claims in both cases require specific treatment steps.
to the application of a drug to treat a particular disease.
See Mayo, 566 U.S. at 74, 87; Vanda, 887 F.3d at 1134.
It’s important for companies in every industry to be informed at an early stage about relevant or even dangerous patents. Not just to monitor competition, but also to understand who is investing in the next technology trend that will change or even disrupt future markets. While most patent information is freely available online, it has become impossible to systematically analyse and understand more than 500,000 new patent applications every month, over 400,000 new research articles, or over 40,000 newly founded startups.
Increased connectivity will result in more and more patented solutions being used in smartphones, computers, cars, machines, meters or even medical devices, as strategically placed patents can block entire industries. And recent patent disputes such as Broadcom’s billion-dollar lawsuit against Volkswagen demonstrate the sums involved.
claim and partnership claims. The jury found against Mr.
he meaningfully contributed to the glottiscope design embodied by U.S. Patent No. 6,955,645.
But JNOV went against DeVona, and the CAFC affirmed.
traffic data,” and affirm its summary judgment of no anticipation.
damages. We also vacate the district court’s award of attorneys’ fees and remand for recalculation.
sales of products that were actually found to infringe or are not colorably different.
Accordingly, we affirm-in-part, vacate-in-part, and remand for further proceedings consistent with this opinion.
We review de novo whether a claim is drawn to patenteligible subject matter.
Labs., Inc., 566 U.S. 66, 70–71 (2012) (citing Diamond v.
Diehr, 450 U.S. 175, 185 (1981)).
an abstract idea. Alice Corp. v. CLS Bank Int’l, 573 U.S.
the additional elements ‘transform the nature of the claim’ into a patent-eligible application.” Id.
the words ‘apply it.’” Id. at 221 (quoting Mayo, 566 U.S.
at 72 (internal alterations omitted)).
conclude that claim 1 is not directed to an abstract idea.
detect large-scale attacks. Enfish, 822 F.3d at 1335–36.
review the district court’s summary judgment of no anticipation under regional circuit law.
814 F.2d 628, 631 (Fed. Cir. 1987).
over the reference was confirmed in multiple reexamination and litigation proceedings.
based on “direct examination” of network packets to distinguish EMERALD 1997.
of packet data.”); J.A. 27101 (same).
connection requests. Nor does Cisco’s expert testimony create a genuine issue of fact on this issue.
both inconsistent and “based on  multiple layers of supposition.” Summary Judgment Op., 179 F. Supp. 3d at 358.
EMERALD 1997 disclosed analyzing the specific enumerated types of network traffic data recited in the claims.
the jury’s willfulness finding is not supported by substantial evidence.
and therefore vacate and remand.
No need for engineers to read patents??
case and presented a more limited case of willful infringement from 2012 onwards.
filed a motion for summary judgment of no willful infringement prior to May 8, 2012.
at step two, and reverse the district court’s finding of eligibility. Because I would find the claims at issue to be ineligible, I would not reach the remaining issues in the case.
Natural Alternatives wins 101 appeal at CAFC: We live in the natural world, and all inventions are constrained by the laws of nature.
8,993,610, 8,470,865, and RE45,947 are not patent eligible.
that the claims are not patent eligible, we reverse and remand.
pleadings de novo. Newton v. Parker Drilling Mgmt.
The Method Claims at issue are treatment claims.
judgment on the pleadings was inappropriate.
Moreover, at step two, factual impediments exist to resolving the case at this stage.
natural or conventional food.” J.A. 581 (emphasis added).
to defend the eligibility of the ’947 patent in future proceedings.
characteristics and can be used in a manner that beta-alanine as it appears in nature cannot.
claimed combination is “directed to” ineligible subject matter.
for the proposition that any combination of ineligible subject matter is itself ineligible.
always had,” and the “combination of species produce[d] . . .
effects allowing for outcomes that the individual components could not have.
and we remand for further proceedings consistent with this opinion.
Since 2014, a paper in The Lancet describing the results of a clinical trial using supposed cardiac stem cells has sat with an editors’ expression of concern looming over it. Now, the journal has retracted the paper—the 16th retraction for Piero Anversa, formerly of Harvard Medical School and Brigham and Women’s Hospital.
In October, Harvard Medical School and Brigham and Women’s Hospital determined that 31 papers from the Anversa lab ought to be retracted. By Retraction Watch’s reporting, it’s not clear whether the 2011 paper in The Lancet was among the 31, but the expression of concern came about because the institutions gave the journal a heads up that they were investigating the “integrity of certain data” in the paper, the editors wrote at the time.
The cardiac stem cells given to patients in the clinical trial have been the subject of intense scrutiny by outside investigators, who have found that these “c-kit positive” cells don’t have regenerative capabilities in adult rodent hearts. Clinical trials continue to use c-kit cardiac stem cells.
infringe claim 4 was clearly erroneous. We have jurisdiction under 28 U.S.C. § 1295(a)(1).
and remand for it to reconsider infringement under a corrected claim construction.
they affect the district court’s obviousness analysis.
to combine and its impact on the obviousness analysis.
a plurality of values” limitation lacks substantial evidence.
questioned function.” Id. (emphasis in original).
locate a given binary object within a file.
interfere with prescribers' independent professional judgment.
nurse, dentist, or optometrist licensed pursuant to Title 45 of the Revised Statutes.
"Prescriber" does not include a licensee who is an employee, as defined in N.J.A.C.
18:35-7.1, of a pharmaceutical manufacturer who does not provide patient care.
on the topic(s) being presented.
payments for royalties and licensing fees are not subject to this cap.
in what's considered one of the leading causes of the deadly opioid crisis.
and other compensation that licensed prescribers in New Jersey may accept from pharmaceutical companies.
participation on advisory boards and consulting arrangements. Contracts entered before Tuesday do not apply.
The new cap does not apply to payments related to research and education events.
a cap on the number of meals at four per year, per manufacturer, but that was removed following public comment.
with a manufacturer's logo — anything that would benefit the prescriber or staff.
with nearly 40 bringing in at least $200,000.
making New Jersey unique when compared to other states with caps in place.
of the Partnership for a Drug-Free New Jersey, told New Jersey 101.5.
Those delivering the talks get training that involves learning drug makers’ most important marketing messages.
And they receive anywhere from $500 to $5,000 for each talk they give, with some doctors earning more than $100,000 annually.
president of the Institute on Medicine as a Profession at Columbia University.
may be to influence them instead of the secretaries, many doctors said they had never thought of that.
who earned more than $16,000 from 2003 to 2005 doing educational talks for drug makers.
or take a more nuanced approach, will become evident as the industry works quickly to adapt to the new law.
collaboration, communication, and attention to detail, compliance is achievable.
However, Vitale noted that he would like to see the proposal pass through the legislature for debate – something that many in Christie’s political party harped on about the Obama Administration’s implementation of the Affordable Care Act. As we have seen time and time again, many politicians can argue either side of the coin, depending on who is in charge.
The new regulation which was submitted last week to the Office of Administrative law and will be published on October 2, 2017, in the New Jersey Register must undergo a public hearing before it is implemented, but that doesn’t necessarily mean that changes will be made. The public hearing is expected to be held on October 19, 2017, in the Monmouth Room at the Division of Consumer Affairs in Newark.
Well, I, I, I hear these stories that are — that’s the story of the day, about Democrats moving to the left.
— betrays workers and utters racist, anti-Semitic rhetoric. And nobody in their party calls him out.
They don’t have divisions. They’ve all followed his racist actions and betrayal of workers.
between and among Democrats. That’s the real story.
Apart from Brown's attempt to give lemmings a bad name, one notes that Ohio Republican John Kasich has been criticizing President Trump.
Well, there's actually anti-Semitism that has crept into our discourse.
Look at George Soros, okay? The Republican and conservative attacks on George Soros over the years.
In fact, Kevin McCarthy had to pull one tweet that implied that he was essentially trying to buy this or buy that.
-- and it’s getting a little old.
Finally, Todd ended the show with the line "That's all I have for today."
"60 Minutes" on 10 March 2019 with Jerome Powell; and was Ben Bernanke right about what Lincoln said??
during their stints at the helm of the nation's central bank.
to bring many voices to the table, to listen carefully."
So the best thing to do is to make what you believe is the right call."
Public Papers of the Presidents of the United States: Richard Nixon, 1969, p. 909.
I do the very best I know how—the very best I can; and I mean to keep doing so until the end.
If the end brings me out all right, what is said against me won’t amount to anything.
If the end brings me out wrong, ten angels swearing I was right would make no difference.
President ABRAHAM LINCOLN.—Francis Carpenter, Six Months at the White House, pp. 258–59 (1867).
speaking of the inadequacy of defenses to a wrong decision.
our banking system through the computer system?
POWELL: So cyber risk is a major focus. Perhaps the major focus in terms of big risks.
to build up resilience against those. Cyber risk is a constantly evolving risk.
to protect financial institutions and the financial markets. And private corporations do the same thing.
The banks we supervise are required to have plans in place and state of the art, you know, technology and the like.
I would say for cyber risk though I've never felt a time when I think we're doing enough.
We just have to keep running hard to keep up with the risk.
PELLEY: I have the sense that I just hit on the thing that keeps you up at night.
POWELL: I would say of the risks that we face, that certainly is the largest one.
POWELL: But we have longer run issues. And it would be important for us as a nation to address these issues.
In particular, you're not counted as unemployed if you haven't looked for a job in the last four weeks.
And we have an unusually large number of people in their prime working years who are not in the labor force.
The United States has a lower labor force participation rate than almost every other advanced country.
so that they can contribute to our shared prosperity and reap the benefits of doing so.
The economy will be stronger and the country will be stronger if we can do that.
Not all of the tools to accomplish that are the Fed's. Many of them are in the hands of Congress.
PELLEY: Where did these people go who are no longer looking for work?
POWELL: They went a lot of places. Many of them are discouraged from finding work.
There are a range of causes, really. And part of it is evolving technology.
So as technology evolves, it requires rising skills on the part of the people.
U.S. educational attainment has not moved up as rapidly as it has in other countries.
has moved into developing countries. And so the manufacturing employment and the manufacturing base is smaller than it was.
particularly young males, who would be better off in the labor force, and the country would be better off for it as well.
POWELL: That no one is talking about? I would point to our longer-run challenges.
So, the U.S. economy right now is in a pretty good place. Unemployment is at a 50-year low.
Inflation is close to its target. We are growing at a reasonable rate. But we face longer-run challenges.
And I would like to see a stronger national focus on, for example, labor force participation.
There are plenty of prime-aged people who are not in the labor force and who would be better off in the labor force.
And I'd like to see us find policies that can support and reward work, provide training and education, and generally try to raise U.S. labor force participation so that we're no longer at the bottom of the league table among advanced economies. I think that's a win-win. That gives us faster growth. It gives us more widespread prosperity. These people can contribute to our shared prosperity, and they can also benefit from doing so.
will work for less money.
See 2012 post on IPBiz Startup Act 2.0: are you turning up your nose at $150K/year jobs?
was offered the opportunity to keep his job, in India at the prevailing salary in India [20 to 25% of US].
This "complete" transcript does NOT include the Bernanke text.
evidence it offers to show secondary considerations of nonobviousness.
We do not reach that issue for two reasons.
limited evidentiary record on this issue.
Board’s treatment of claims 10, 15, and 25.
simply not at issue before the Board.
CAFC affirms the meaning of "immediate" as being "within about 5–10 minutes"
The CAFC affirm D. Mass. in BRIGHAM AND WOMEN'S HOSPITAL v. PERRIGO COMPANY.
of the police shooting in Sacramento, and the unmanned SpaceX probe.
There was a bit of trivia, with a note that January became the first month of the calendar year in 450 BCI.
did a more downbeat story, noting that 15% of Wisconsin's dairy farmers ceased business in 2018.
Moment of nature did the Grand Canyon, celebrating its 100th anniversary as a national park.

References: v.

 § 101
 v.

 v.

 v.

 v. 
 v. 
 § 1295
 v.